Anti-ATS20/ ADAMTS20/ ADAM-TS20 functional antibody

Anti-ATS20/ ADAMTS20/ ADAM-TS20 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ADAMTS20/ADAMTS20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0645-Ab-1/ GM-Tg-hg-SE0645-Ab-2Anti-Human ADAMTS20 monoclonal antibodyHuman
GM-Tg-rg-SE0645-Ab-1/ GM-Tg-rg-SE0645-Ab-2Anti-Rat ADAMTS20 monoclonal antibodyRat
GM-Tg-mg-SE0645-Ab-1/ GM-Tg-mg-SE0645-Ab-2Anti-Mouse ADAMTS20 monoclonal antibodyMouse
GM-Tg-cynog-SE0645-Ab-1/ GM-Tg-cynog-SE0645-Ab-2Anti-Cynomolgus/ Rhesus macaque ADAMTS20 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0645-Ab-1/ GM-Tg-felg-SE0645-Ab-2Anti-Feline ADAMTS20 monoclonal antibodyFeline
GM-Tg-cang-SE0645-Ab-1/ GM-Tg-cang-SE0645-Ab-2Anti-Canine ADAMTS20 monoclonal antibodyCanine
GM-Tg-bovg-SE0645-Ab-1/ GM-Tg-bovg-SE0645-Ab-2Anti-Bovine ADAMTS20 monoclonal antibodyBovine
GM-Tg-equg-SE0645-Ab-1/ GM-Tg-equg-SE0645-Ab-2Anti-Equine ADAMTS20 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0645-Ab-1/ GM-Tg-hg-SE0645-Ab-2; GM-Tg-rg-SE0645-Ab-1/ GM-Tg-rg-SE0645-Ab-2;
GM-Tg-mg-SE0645-Ab-1/ GM-Tg-mg-SE0645-Ab-2; GM-Tg-cynog-SE0645-Ab-1/ GM-Tg-cynog-SE0645-Ab-2;
GM-Tg-felg-SE0645-Ab-1/ GM-Tg-felg-SE0645-Ab-2; GM-Tg-cang-SE0645-Ab-1/ GM-Tg-cang-SE0645-Ab-2;
GM-Tg-bovg-SE0645-Ab-1/ GM-Tg-bovg-SE0645-Ab-2; GM-Tg-equg-SE0645-Ab-1/ GM-Tg-equg-SE0645-Ab-2
Products NameAnti-ADAMTS20 monoclonal antibody
Formatmab
Target NameADAMTS20
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADAMTS20 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0645-Ag-1Recombinant multi-species ATS20/ ADAMTS20/ ADAM-TS20 protein


    Target information

    Target IDGM-SE0645
    Target NameADAMTS20
    Gene ID80070,223838,315263,699935,486602,101080805,536137,100054665
    Gene Symbol and SynonymsADAM-TS20,Adamst20,ADAMTS-20,ADAMTS20,bt,GON-1
    Uniprot AccessionP59510
    Uniprot Entry NameATS20_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173157
    Target ClassificationN/A

    The target: ADAMTS20, gene name: ADAMTS20, also named as ADAM-TS20, ADAMTS-20, GON-1. The protein encoded by this gene is a member of the ADAMTS family of zinc-dependent proteases. The encoded protein has a signal peptide that is cleaved to release the mature peptide, which is secreted and found in the extracellular matrix. This protein may be involved in tissue remodeling. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.